In this regard, it was shown that there was a substantial increase in dyslipidemia and body weight and amplified liver function, together with the dysfunction of adipocytes and the increase of serum TNF-α and leptin and a noticeable decrease in adiponectin levels and elevated expression of TLR4 in the adipose tissue and liver. Here, ADIPOQ is linked to metabolic syndrome.